TAVR Finances: William O’Neill, MD

Interviewed by Steven E. Greer, MD

The clinical adoption of  Transcatheter Aortic Valve Replacement (TAVR) has been slower than expected due to reimbursement rates that cause most cases to be financial losses for the medical centers. We discussed the issue with TAVR pioneer, William O’Neill, MD, of the Henry Ford Hospital.

This entry was posted in Cardiac surgery, Cardiology, Henry Ford. Bookmark the permalink.

Leave a Reply